<p><strong>新加坡，2026 年 1 月 23 日（全球新闻通讯社）-- Basel Medical Group Ltd</strong>（纳斯达克：BMGL）（“公司”）今天宣布，已收到纳斯达克的通知，根据公司股票在过去 30 个连续交易日的收盘买入价，公司不再符合纳斯达克上市规则（“规则”）中维持每股最低买入价 1 美元的要求。</p>
<p>规则为公司提供了 180 个日历天的合规期，以便重新获得合规。如果在这 180 天期间内，公司证券的收盘买入价至少为 1 美元，且持续十个连续交易日，纳斯达克将向您提供合规的书面确认。如果公司选择实施反向股票拆分，必须在 2026 年 7 月 21 日到期日前的十个交易日内完成拆分，以便重新获得合规。如果公司未能重新获得合规，公司可能有资格获得额外的时间。为了符合资格，公司需要满足公开持股的市场价值的持续上市要求以及纳斯达克资本市场的所有其他初始上市标准，除了买入价要求，并需要在第二个合规期内提供书面通知，表明其意图通过必要时实施反向股票拆分来弥补缺陷。如果公司满足这些要求，纳斯达克将通知公司已获得额外的 180 个日历天。然而，如果工作人员认为公司无法弥补缺陷，或者公司其他方面不符合资格，纳斯达克将通知其证券将面临退市。</p>
<p>公司目前正在与专业顾问合作，准备整改计划，以解决上述不合规问题。公司股票在纳斯达克的交易目前未受到此类不合规的影响。</p>
<p><strong>关于 Basel Medical Group Ltd</strong></p>
<p>Basel Medical 是一家总部位于新加坡的骨科和创伤服务、运动医学、骨科手术及神经外科治疗、行政健康筛查服务、职业医学、康复、心理健康和妇女健康以及普通医疗的提供者。我们的运营基地位于新加坡，诊所分布在新达城购物中心、麦克弗森路、陶波、玛格丽特大道、淡滨尼、东大门和格伦伊格尔斯医疗中心。在过去的 20 年里，我们的集团与大量企业建立了强大而持久的关系，特别是在建筑、海洋和石油天然气行业，这些关系支撑了我们强大的商业模式。作为一家在新加坡拥有超过 20 年业绩记录的医疗服务提供者，我们在把握新加坡及东南亚私人医疗行业的增长机会方面处于良好位置，这些机会受到老龄化人口、收入水平上升、私人保险覆盖率增加、政府在医疗保健上的努力和支出、体育参与率上升以及新加坡作为亚洲医疗服务优质目的地的地位推动。我们的管理和医疗团队由一批骨科和神经外科专家、全科医生、企业财务和医疗合作专家组成。Basel Medical Group Ltd 作为我们集团的控股公司，通过位于新加坡的运营子公司开展业务。有关更多信息，请访问公司网站：www.baselmedical.com。</p>
<p><strong>前瞻性声明</strong></p>
<p>本公告中的某些声明为前瞻性声明，涉及已知和未知的风险和不确定性，并基于公司对可能影响其财务状况、经营结果、商业战略和财务需求的未来事件的当前预期和预测。投资者可以通过使用 “目标”、“预期”、“相信”、“估计”、“期望”、“向前看”、“打算”、“可能”、“计划”、“潜在”、“预测”、“提议”、“寻求”、“应该”、“将”、“会” 或其他类似表达在本新闻稿中找到许多（但不是全部）这样的声明。公司没有义务公开更新或修订任何前瞻性声明，以反映后续发生的事件或情况，或其预期的变化，除非法律要求。尽管公司相信这些前瞻性声明中表达的预期是合理的，但无法保证这些预期会正确实现，公司提醒投资者，实际结果可能与预期结果有重大差异，并鼓励投资者查看可能影响其未来结果的其他因素，这些因素在公司向 SEC 的备案中有所说明。</p>
<p><strong>媒体联系：</strong></p>
<p>Basel Medical Group Ltd</p>
<p>+65 6291 9188</p>
<p>contact@baselmedical.com</p>
<p>www.baselmedical.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1UWXhNQ00zTXpjNE5ERTNJelV3TURFek1EUTNPUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1UWXhNQ00zTXpjNE5ERTNJelV3TURFek1EUTNPUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png"/></p>

标普全球医疗股指数 ETF - iShares

美国医疗保健供应商 ETF - iShares

标普医疗保健服务 ETF - SPDR

BMGL

医疗业 ETF - SPDR

医疗业 ETF - Vanguard

<p>巴塞尔医疗集团有限公司（Nasdaq: BMGL）已收到纳斯达克关于未符合每股最低出价要求 1 美元的通知。该公司有 180 天的合规期来恢复合规，如果收盘出价连续十天达到 1 美元即可实现合规。公司正在考虑进行反向股票拆分，并准备整改计划。目前，其股票交易未受到此不合规的影响</p>

<p><strong>Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd</strong> (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company’s shares for the last 30 consecutive business days, the Company no longer meets the requirements under Nasdaq’s Listing Rules (the “Rules”) for listed securities to maintain a minimum bid price of $1 per share.</p>
<div class="lb-trans"><p><strong>新加坡，2026 年 1 月 23 日（全球新闻通讯社）-- Basel Medical Group Ltd</strong>（纳斯达克：BMGL）（“公司”）今天宣布，已收到纳斯达克的通知，根据公司股票在过去 30 个连续交易日的收盘买入价，公司不再符合纳斯达克上市规则（“规则”）中维持每股最低买入价 1 美元的要求。</p>
</div><p>The Rules provide the Company a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company’s security is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide you written confirmation of compliance. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten business days prior to the expiration date of July 21, 2026, in order to regain compliance. In the event the Company does not regain compliance, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting.</p>
<div class="lb-trans"><p>规则为公司提供了 180 个日历天的合规期，以便重新获得合规。如果在这 180 天期间内，公司证券的收盘买入价至少为 1 美元，且持续十个连续交易日，纳斯达克将向您提供合规的书面确认。如果公司选择实施反向股票拆分，必须在 2026 年 7 月 21 日到期日前的十个交易日内完成拆分，以便重新获得合规。如果公司未能重新获得合规，公司可能有资格获得额外的时间。为了符合资格，公司需要满足公开持股的市场价值的持续上市要求以及纳斯达克资本市场的所有其他初始上市标准，除了买入价要求，并需要在第二个合规期内提供书面通知，表明其意图通过必要时实施反向股票拆分来弥补缺陷。如果公司满足这些要求，纳斯达克将通知公司已获得额外的 180 个日历天。然而，如果工作人员认为公司无法弥补缺陷，或者公司其他方面不符合资格，纳斯达克将通知其证券将面临退市。</p>
</div><p>The Company is currently working with its professional advisers to prepare a rectification plan to remedy the above mentioned non-compliance. Trading of the Company’s shares on Nasdaq is not currently affected by such non-compliance.</p>
<div class="lb-trans"><p>公司目前正在与专业顾问合作，准备整改计划，以解决上述不合规问题。公司股票在纳斯达克的交易目前未受到此类不合规的影响。</p>
</div><p><strong>About Basel Medical Group Ltd</strong></p>
<div class="lb-trans"><p><strong>关于 Basel Medical Group Ltd</strong></p>
</div><p>Basel Medical is a Singapore-based provider of orthopedic and trauma services, sports medicine, orthopedic procedures and surgery, as well as neurosurgical treatments, executive health screening services, occupational medicine, rehabilitation, mental and women’s health and general practices. Our operations are based in Singapore, with our clinics being located at Suntec City Mall, Macpherson Road, Toa Payoh, Margaret Drive, Tampines, Gateway East and Gleneagles Medical Centre. Over the last 20 years, our group has forged strong and lasting relationships with a large base of corporations, in particular those in the construction, marine and oil &amp; gas industries, which underpin our robust business model. As an medical service provider in Singapore with a track record of over 20 years, we are well-positioned to ride the wave of growth opportunities in the private healthcare industry in Singapore and across Southeast Asia driven by ageing populations, rising income levels, increasing private insurance coverage, government effort and expenditure on healthcare, growing sports participation rate and Singapore’s position as a premium destination for healthcare services in Asia. Our management and medical practitioner team comprises a roster of orthopedic and neurosurgery specialists, general practitioners, corporate finance and healthcare partnership specialists. Basel Medical Group Ltd serves as the holding company of our group and we conduct our operations through our operating subsidiaries based in Singapore. For more information, please visit the Company’s website: www.baselmedical.com.</p>
<div class="lb-trans"><p>Basel Medical 是一家总部位于新加坡的骨科和创伤服务、运动医学、骨科手术及神经外科治疗、行政健康筛查服务、职业医学、康复、心理健康和妇女健康以及普通医疗的提供者。我们的运营基地位于新加坡，诊所分布在新达城购物中心、麦克弗森路、陶波、玛格丽特大道、淡滨尼、东大门和格伦伊格尔斯医疗中心。在过去的 20 年里，我们的集团与大量企业建立了强大而持久的关系，特别是在建筑、海洋和石油天然气行业，这些关系支撑了我们强大的商业模式。作为一家在新加坡拥有超过 20 年业绩记录的医疗服务提供者，我们在把握新加坡及东南亚私人医疗行业的增长机会方面处于良好位置，这些机会受到老龄化人口、收入水平上升、私人保险覆盖率增加、政府在医疗保健上的努力和支出、体育参与率上升以及新加坡作为亚洲医疗服务优质目的地的地位推动。我们的管理和医疗团队由一批骨科和神经外科专家、全科医生、企业财务和医疗合作专家组成。Basel Medical Group Ltd 作为我们集团的控股公司，通过位于新加坡的运营子公司开展业务。有关更多信息，请访问公司网站：www.baselmedical.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>Certain statements in this announcement are forward-looking statements, which involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “aim”, “anticipate”, “believe”, “estimate”, “expect”, “going forward”, “intend”, “may”, “plan”, “potential”, “predict”, “propose”, “seek”, “should”, “will”, “would” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC.</p>
<div class="lb-trans"><p>本公告中的某些声明为前瞻性声明，涉及已知和未知的风险和不确定性，并基于公司对可能影响其财务状况、经营结果、商业战略和财务需求的未来事件的当前预期和预测。投资者可以通过使用 “目标”、“预期”、“相信”、“估计”、“期望”、“向前看”、“打算”、“可能”、“计划”、“潜在”、“预测”、“提议”、“寻求”、“应该”、“将”、“会” 或其他类似表达在本新闻稿中找到许多（但不是全部）这样的声明。公司没有义务公开更新或修订任何前瞻性声明，以反映后续发生的事件或情况，或其预期的变化，除非法律要求。尽管公司相信这些前瞻性声明中表达的预期是合理的，但无法保证这些预期会正确实现，公司提醒投资者，实际结果可能与预期结果有重大差异，并鼓励投资者查看可能影响其未来结果的其他因素，这些因素在公司向 SEC 的备案中有所说明。</p>
</div><p><strong>Media Contact:</strong></p>
<div class="lb-trans"><p><strong>媒体联系：</strong></p>
</div><p>Basel Medical Group Ltd</p>
<div class="lb-trans"><p>Basel Medical Group Ltd</p>
</div><p>+65 6291 9188</p>
<div class="lb-trans"><p>+65 6291 9188</p>
</div><p>contact@baselmedical.com</p>
<div class="lb-trans"><p>contact@baselmedical.com</p>
</div><p>www.baselmedical.com</p>
<div class="lb-trans"><p>www.baselmedical.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1UWXhNQ00zTXpjNE5ERTNJelV3TURFek1EUTNPUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYzMTYxMCM3Mzc4NDE3IzUwMDEzMDQ3OQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png" alt="" original-src="https://ml.globenewswire.com/media/ZjRkMzljOTUtOWVkNC00NTFkLWFjNjgtMzQyNDU0ZWQ2NzdmLTUwMDEzMDQ3OS0yMDI2LTAxLTIzLWVu/tiny/Basel-Medical-Group-Ltd.png"/></p>

BMGL 股票新闻：收到来自纳斯达克的拖欠通知